ManpowerGroup Stock Plummets 20% Since Q3 Earnings Meet Estimates

ManpowerGroup shares fell 20% after Q3 revenue of $4.84 billion missed consensus by 1.4%, although adjusted EPS of $1.01 matched estimates and rose 22% year over year. Revenue increased 4% overall, with Americas up 13%, while gross margin contracted 70 basis points to 15.9%; free cash flow was a $17 million outflow. Q4 revenue is forecast to grow 3%-7%, but the $1.08 midpoint of adjusted EPS guidance is below the $1.10 consensus; management targets $200 million in annual cost savings by 2028.

Analysis

MAN’s weak point is not merely a small sales miss: gross-margin contraction alongside low operating margins leaves little room for further demand or mix deterioration. The 22% EPS growth appears more dependent on expense discipline than improving unit economics; promised savings through 2028 are an execution buffer, not yet evidence of durable operating leverage. Regional growth is also uneven: strength in the Americas and Northern Europe must offset a much larger Southern Europe base that is barely growing. That makes consolidated growth vulnerable if the stronger regions cool.

The 20% share decline may already discount a cautious near-term outlook, so chasing a short risks a sharp reversal if US staffing demand and Experis improve. Conversely, reported revenue growth guidance does not resolve the margin question: monitor organic growth, gross margin, and whether savings convert to adjusted EBITA rather than being absorbed by mix or restructuring costs. Debt is manageable on the reported figures, but repeated weak cash conversion would make the cost program more consequential.

ACN and FDS results provide a useful contrast in their own businesses, not proof of a broad labor-market rebound or a direct read-through to MAN. Over 1–3 months, the key catalyst is MAN’s Q4 delivery against regional growth and margin guidance; over 6–18 months, the thesis turns on sustained savings and normalization of staffing mix. A move back toward organic growth with gross-margin stabilization would falsify the bearish operating thesis.

Key Decisions for Investors

• Do not chase the post-earnings MAN decline. Keep exposure underweight pending evidence that gross margin has stabilized; the downside case is deteriorating organic demand or a failure to translate cost savings into operating profit.
• Use MAN’s next results as the confirmation point: track constant-currency organic growth by region, gross margin versus the 15.8%–16% outlook, adjusted EBITA margin, and cash conversion. A miss on both margin and organic growth strengthens the negative thesis; stabilization would argue against adding to shorts.
• Treat a relative long-ACN/short-MAN position only as a monitored, modest expression of divergent reported momentum—not a valuation call. Reassess if ACN’s growth or guidance weakens, or if MAN delivers margin stabilization and broad-based organic growth.